Monensin Sodium — Veterinary Vademecum Drug Reference

Dosage & Administration Guidelines

Species	Route	Dose	Frequency	Duration & Clinical Notes
Cattle (beef and dairy)	Oral (in feed or as a premix)	Feed additive: 5-30 g/ton of complete feed (typical range 10-30 g/ton for feed efficiency; 15-30 g/ton for coccidiosis control)	Continuous feeding	Duration: Throughout the feeding period or as directed by a veterinarian Notes: For coccidiosis prevention, use higher end of the dose range. Ensure thorough mixing to avoid toxicity.
Sheep	Oral (in feed)	Feed additive: 10-25 g/ton of complete feed (typical 15-25 g/ton for feed efficiency; 20-25 g/ton for coccidiosis)	Continuous feeding	Duration: Throughout the feeding period or as directed Notes: Not approved for goats in all regions; consult local regulations.
Poultry (broiler chickens)	Oral (in feed)	Feed additive: 90-110 g/ton of complete feed (typical 100 g/ton)	Continuous feeding	Duration: Throughout the grow-out period Notes: Do not use in laying hens. Withdraw 5 days before slaughter.
Poultry (turkeys)	Oral (in feed)	Feed additive: 54-90 g/ton of complete feed (typical 60-90 g/ton)	Continuous feeding	Duration: Throughout the grow-out period Notes: Do not use in laying hens. Withdraw 5 days before slaughter.

Clinical Indications & Species Uses

General Indications

Monensin is primarily used in cattle, sheep, and poultry for improving feed efficiency and preventing coccidiosis.

Cattle (Bovine)

Improvement of feed efficiency
Prevention and control of coccidiosis (Eimeria bovis, E. zuernii)
Reduction of bloat (frothy bloat) in pasture-fed cattle

Small Ruminants (Sheep / Goat)

Improvement of feed efficiency in sheep
Prevention and control of coccidiosis in sheep and goats (Eimeria species)

Avian & Poultry

Prevention of coccidiosis in broiler chickens and turkeys (Eimeria species)

Pharmacology & Mechanism of Action

Drug Class: Ionophore Antibiotic | Pharmacological Group: Carboxylic Polyether Ionophore

Mechanism of Action: Monensin is a carboxylic polyether ionophore that forms lipophilic complexes with monovalent cations (primarily Na+) and facilitates their transport across biological membranes. In susceptible bacteria and coccidia, this ionophoric action disrupts the normal transmembrane ion gradient, leading to an influx of sodium and efflux of potassium, which in turn causes osmotic swelling, loss of intracellular homeostasis, and ultimately cell death. In ruminants, monensin alters rumen fermentation by selectively inhibiting Gram-positive bacteria, thereby reducing methane production, decreasing acetate/propionate ratio, and improving feed efficiency. It also has anticoccidial activity against Eimeria species by interfering with the energy metabolism of the parasite.

Pharmacodynamics: Monensin exhibits antimicrobial activity primarily against Gram-positive bacteria and coccidia. In cattle and sheep, it improves feed efficiency and weight gain by modulating rumen microbial populations, increasing propionate production, and decreasing methane and ammonia production. It also reduces the incidence of bloat and acidosis by stabilizing rumen pH. In poultry, monensin is used for the prevention of coccidiosis caused by Eimeria species. Its efficacy is dose-dependent, and it has a wide margin of safety in target species when used appropriately, but it is extremely toxic to horses and other equids.

⚡ Pharmacokinetics Summary

Absorption: Monensin is poorly absorbed from the gastrointestinal tract in ruminants and poultry. After oral administration, the majority of the drug remains in the gastrointestinal lumen, where it exerts its local effects. Systemic absorption is minimal, with less than 5% of the administered dose reaching the bloodstream.

Distribution: Due to its lipophilic nature, monensin distributes widely in tissues, but because of low systemic absorption, tissue residues are generally low. It is primarily concentrated in the liver and bile, with some distribution to fat and muscle. In poultry, residues may be found in eggs if administered to laying hens, but it is not approved for use in laying hens.

Metabolism: Monensin is extensively metabolized in the liver, primarily via oxidative pathways, resulting in multiple metabolites. The metabolism is rapid, and the parent compound is rarely detected in plasma. The metabolites are excreted in bile and feces.

Excretion: The primary route of excretion is via the feces, as the drug and its metabolites are eliminated in bile. A small fraction may be excreted in urine. In ruminants, the majority of the administered dose is recovered in feces within 48-72 hours.

Half-Life: The elimination half-life in cattle is approximately 1-2 days, but due to minimal systemic absorption, the effective half-life in the gastrointestinal tract is longer. In poultry, the half-life is shorter, around 12-24 hours.

Bioavailability: Oral bioavailability is low, typically less than 5% in ruminants and poultry, due to poor absorption and extensive first-pass metabolism.

Protein Binding: Monensin is highly protein-bound in plasma, with binding exceeding 90% in most species.

Available Formulations & Strengths

Premix (feed additive) Various concentrations, e.g., 20%, 40%, 60% monensin sodium (Oral (mixed in feed))

Oral solution (for cattle) e.g., 200 mg/mL (for drenching) (Oral)

Contraindications & Clinical Warnings

Contraindications:

Do not use in horses or other equids - extremely toxic and can be fatal.
Do not use in dogs and cats - not indicated and potentially toxic.
Do not use in lactating dairy cattle (in some countries) - milk withdrawal not established.
Do not use in laying hens (poultry) - residues in eggs.
Do not use in animals with known hypersensitivity to monensin.
Do not use in animals with severe hepatic or renal impairment.

Warnings & Clinical Precautions:

Extremely toxic to horses - accidental exposure can cause fatal cardiac and skeletal muscle damage.
Must be thoroughly mixed in feed to avoid toxicity from concentrated pockets.
Do not feed to animals receiving tiamulin or other ionophore-interacting drugs (see drug interactions).
Use with caution in animals with reduced feed intake or illness, as they may consume higher doses relative to body weight.
In cattle, avoid use in animals with severe respiratory disease or stress.
For poultry, do not use in layers or breeders producing eggs for human consumption.
Wear protective equipment when handling the premix to avoid inhalation or skin contact.
Keep out of reach of children and other animals.

Adverse Effects & Reactions

Common:

Reduced feed intake (at high doses)
Mild diarrhea (transient)
Reduced milk production in dairy cows (if used improperly)

Serious / Severe:

Cardiotoxicity (arrhythmias, heart failure) - especially in horses and at high doses
Skeletal muscle damage (rhabdomyolysis) - especially in horses
Death (in overdose or accidental exposure in sensitive species)

Rare:

Allergic reactions (skin rash, anaphylaxis)
Hepatotoxicity (with prolonged high doses)
Nephrotoxicity (rare)

Key Drug Interactions

Interacting Drug / Class	Clinical Effect & Mechanism	Severity
Tiamulin (pleuromutilin antibiotic)	Severe toxicity (cardiac and skeletal muscle damage) when used concurrently or within 7 days of each other in poultry and pigs.	High
Chloramphenicol	May increase the risk of toxicity due to additive effects on mitochondrial function.	Moderate
Sulfonamides	Potential increased risk of toxicity in poultry when used concurrently.	Moderate
Erythromycin	May increase the risk of cardiac toxicity in some species.	Moderate
Other ionophores (e.g., lasalocid, salinomycin)	Additive toxicity; do not use concurrently.	High

Overdose & Toxicity Management

Signs of Toxicity:

In horses: profuse sweating, ataxia, colic, muscle tremors, recumbency, cardiac arrhythmias, and death.
In cattle: decreased feed intake, diarrhea, depression, muscle weakness, and in severe cases, cardiac failure.
In poultry: reduced feed intake, paralysis, and increased mortality.
General: respiratory distress, convulsions, and coma.

Emergency Treatment Protocol: There is no specific antidote. Treatment is symptomatic and supportive. Remove the feed containing monensin immediately. Provide fresh water and high-quality feed. For horses, administer activated charcoal if ingestion is recent, and provide intensive supportive care including intravenous fluids, electrolytes, and cardiac monitoring. In severe cases, euthanasia may be necessary. In cattle and poultry, supportive care with fluids and electrolytes may help, but prognosis is poor if severe signs develop.

Food Animal Withdrawal Times

🥩 Meat: 0 days🥛 Milk: 0 days

Withdrawal times vary by country and formulation. In the US, monensin has a zero-day withdrawal for meat and milk in cattle when used according to label. For poultry, a 5-day withdrawal is required for meat. Not approved for use in laying hens, so egg withdrawal is not applicable. Always follow local regulations.

Storage, Handling & Regulatory Information

Storage Temperature: Store at room temperature (15-30°C) in a dry place.

Handling & Special Conditions: Keep container tightly closed. Avoid exposure to excessive heat and moisture. Store away from feed and food items to prevent accidental contamination.

Dispensing Status: Over-The-Counter (OTC)

Approval Status: Approved for use in cattle (feed efficiency and coccidiosis), sheep (feed efficiency and coccidiosis), and poultry (coccidiosis) in the US. Not approved for horses, dogs, cats, or other species.

Extra-Label (Off-Label) Use: In the US, monensin is a feed additive approved by the FDA for use in cattle, sheep, and poultry. Extra-label use in other species or at higher doses is prohibited under AMDUCA, especially in food animals, due to residue concerns and toxicity risks. In the EU, monensin is approved as a coccidiostat for poultry and as a feed additive for cattle. Always consult a veterinarian for off-label use.

Clinical Pearls & Practice Notes

💡 Clinical Insights: Monensin is a valuable tool in livestock production for improving feed efficiency and controlling coccidiosis. However, its narrow margin of safety in certain species, particularly horses, necessitates strict adherence to label directions and careful feed mixing. It is essential to avoid contamination of feed intended for horses, dogs, and other sensitive animals. In cattle, monensin can also help reduce the incidence of bloat and acidosis. For poultry, it is a widely used anticoccidial, but rotation with other anticoccidials is recommended to prevent resistance. Always monitor animals for signs of toxicity, especially when introducing monensin into the diet. Consult a veterinarian for specific recommendations and to ensure compliance with local regulations.

References & Literature

📚 Plumb's Veterinary Drug Handbook
📚 Papich Veterinary Pharmacology and Therapeutics
📚 Compendium of Veterinary Products (CVP)